DE69521653D1 - Verfahren zur Kontrolle der Strukturstabilität von Kollagenfasern hergestellt aus Lösungen und Dispersionen, behandelt mit Natriumhydroxid für die Deaktivierung von infektiösen Wirkstoffen - Google Patents

Verfahren zur Kontrolle der Strukturstabilität von Kollagenfasern hergestellt aus Lösungen und Dispersionen, behandelt mit Natriumhydroxid für die Deaktivierung von infektiösen Wirkstoffen

Info

Publication number
DE69521653D1
DE69521653D1 DE69521653T DE69521653T DE69521653D1 DE 69521653 D1 DE69521653 D1 DE 69521653D1 DE 69521653 T DE69521653 T DE 69521653T DE 69521653 T DE69521653 T DE 69521653T DE 69521653 D1 DE69521653 D1 DE 69521653D1
Authority
DE
Germany
Prior art keywords
deactivation
dispersions
treated
solutions
controlling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69521653T
Other languages
English (en)
Other versions
DE69521653T2 (de
Inventor
Vivek N Shenoy
Tim T Revak
Ceorge H Chu
Hugh R Mcmullin
Joel S Rosenblatt
Martin, Ph D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiotech Biomaterials Corp
Original Assignee
Cohesion Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cohesion Technologies Inc filed Critical Cohesion Technologies Inc
Publication of DE69521653D1 publication Critical patent/DE69521653D1/de
Application granted granted Critical
Publication of DE69521653T2 publication Critical patent/DE69521653T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F4/00—Monocomponent artificial filaments or the like of proteins; Manufacture thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
DE69521653T 1994-07-13 1995-05-30 Verfahren zur Kontrolle der Strukturstabilität von Kollagenfasern hergestellt aus Lösungen und Dispersionen, behandelt mit Natriumhydroxid für die Deaktivierung von infektiösen Wirkstoffen Expired - Fee Related DE69521653T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/274,673 US5616689A (en) 1994-07-13 1994-07-13 Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation

Publications (2)

Publication Number Publication Date
DE69521653D1 true DE69521653D1 (de) 2001-08-16
DE69521653T2 DE69521653T2 (de) 2002-05-08

Family

ID=23049166

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69521653T Expired - Fee Related DE69521653T2 (de) 1994-07-13 1995-05-30 Verfahren zur Kontrolle der Strukturstabilität von Kollagenfasern hergestellt aus Lösungen und Dispersionen, behandelt mit Natriumhydroxid für die Deaktivierung von infektiösen Wirkstoffen

Country Status (5)

Country Link
US (1) US5616689A (de)
EP (1) EP0696617B1 (de)
JP (1) JPH08169848A (de)
CA (1) CA2146938C (de)
DE (1) DE69521653T2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756678A (en) * 1995-05-01 1998-05-26 Cohesion Technologies, Inc. Prion inactivation in connective tissue materials
AU7977298A (en) 1997-06-18 1999-01-04 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof
US6808707B2 (en) 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20020177223A1 (en) * 2001-03-12 2002-11-28 Ogle Mathew F. Methods and compositions for crosslinking tissue
US7105182B2 (en) * 2001-07-25 2006-09-12 Szymaitis Dennis W Periodontal regeneration composition and method of using same
ES2212870B1 (es) * 2001-08-08 2005-10-01 Consejo Superior De Investigaciones Cientificas Estabilizacion para la conservacion y almacenamiento a temperatura ambiente de pieles y tejido conectivo de peces, y posterior produccion de colageno y/o gelatina.
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
AU2003300379A1 (en) * 2002-12-27 2004-07-29 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collagen and MMPI
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
KR100750780B1 (ko) 2006-03-17 2007-08-20 한국신발피혁연구소 콜라겐과 수용성 고분자 복합체를 이용한 재생 단백질섬유의 제조방법
ES2386972T3 (es) * 2006-05-31 2012-09-10 Genzyme Corporation Uso de polisacáridos para la estimulación de la actividad enzimática
US20080293637A1 (en) * 2007-05-23 2008-11-27 Allergan, Inc. Cross-linked collagen and uses thereof
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
WO2009065116A1 (en) 2007-11-16 2009-05-22 Aspect Pharmaceuticals Llc Compositions and methods for treating purpura
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
EP2324064B1 (de) 2008-09-02 2017-11-08 Tautona Group LP Stränge aus hyaluronsäure und/oder derivaten daraus, herstellungsverfahren und verwendung
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
AU2010348090B2 (en) * 2010-03-12 2015-09-03 Allergan Industrie Sas A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition
ES2729994T3 (es) 2010-03-22 2019-11-07 Allergan Inc Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
EP2549947B1 (de) 2010-03-24 2017-12-13 Covidien LP Dreidimensionales chirurgisches kombinationsimplantat
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
CN103702659B (zh) 2011-06-03 2016-12-21 阿勒根公司 包括抗氧化剂的皮肤填充剂组合物
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US10016527B2 (en) 2012-10-23 2018-07-10 Orthovita, Inc. Materials and methods for repair of cartilage defects
US10722444B2 (en) 2014-09-30 2020-07-28 Allergan Industrie, Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
AU2019229784A1 (en) * 2018-03-08 2020-08-13 Catalent U.K. Swindon Zydis Limited Process to reduce endotoxin in gelatin
CN112575574B (zh) * 2020-12-31 2022-09-27 陕西科技大学 一种官能化纳米片改性胶原纤维及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2934446A (en) * 1955-12-21 1960-04-26 United Shoe Machinery Corp Collagen fiber masses and methods of making the same
US3121049A (en) * 1960-09-19 1964-02-11 Nihon Hikaku Method for colloidally dispersing collagen
US3131130A (en) * 1961-07-31 1964-04-28 Ethicon Inc Method of producing soluble collagen
US3530037A (en) * 1967-03-20 1970-09-22 Tomio Nishihara Method for solubilization of collagen fibers with proteolytic enzymes
US4021522A (en) * 1973-09-10 1977-05-03 Collagen Products Pty. Limited Method of forming collagen dispersions
US4233360A (en) * 1975-10-22 1980-11-11 Collagen Corporation Non-antigenic collagen and articles of manufacture
US4097234A (en) * 1976-12-10 1978-06-27 Nippi, Incorporated Method for preparing dispersion of collagen fiber
SU1010164A1 (ru) * 1981-07-17 1983-04-07 Ленинградский ордена Трудового Красного Знамени институт текстильной и легкой промышленности им.С.М.Кирова Способ получени раствора дл формовани волокон из коллагена
FR2516927B1 (fr) * 1981-11-26 1986-05-23 Merieux Fond Procede de preparation industrielle de materiaux collageniques a partir de tissus placentaires humains, materiaux collageniques humains obtenus, leur application comme biomateriaux
JPS63502354A (ja) * 1986-01-06 1988-09-08 ザ　ユニヴァーシティ　オブ　メルボルン コラ−ゲン生産物
US5306500A (en) * 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
US5304595A (en) * 1988-11-21 1994-04-19 Collagen Corporation Collagen-polymer conjugates
US5264214A (en) * 1988-11-21 1993-11-23 Collagen Corporation Composition for bone repair
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates

Also Published As

Publication number Publication date
CA2146938C (en) 1999-05-18
EP0696617A3 (de) 1997-03-12
JPH08169848A (ja) 1996-07-02
EP0696617B1 (de) 2001-07-11
CA2146938A1 (en) 1996-01-14
DE69521653T2 (de) 2002-05-08
EP0696617A2 (de) 1996-02-14
US5616689A (en) 1997-04-01

Similar Documents

Publication Publication Date Title
DE69521653T2 (de) Verfahren zur Kontrolle der Strukturstabilität von Kollagenfasern hergestellt aus Lösungen und Dispersionen, behandelt mit Natriumhydroxid für die Deaktivierung von infektiösen Wirkstoffen
DE59607490D1 (de) Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix
DE69520450D1 (de) Verfahren zur Herstellung von Polyolefinen in Gegenwart von Katalysatorsystemen sowie Katalysatorsysteme, die Azametallocene enthalten
DE69113129T2 (de) Verfahren und Vorrichtung für die Herstellung von sterilen wässrigen Lösungen.
DE69509087D1 (de) Verfahren zur herstellung von absorbierenden artikeln mit einwärts gebogenen dichten beinrändern
DE69415034D1 (de) Neue xylanase, verfahren zur herstellung derselben, methode zur behandlung von papierbrei, und herstellung von xylo-oligosacchariden
DE69333463D1 (de) Alkalische Proteasen produzierende Bakterien, und Verfahren zur Herstellung dieser alkalischen Proteasen
CH684514GA3 (de) Verfahren zur Herstellung von wässrigen Dispersionen von oxydierten Schwefelfarbstoffen.
DE59500700D1 (de) Verfahren und Mittel zur Herstellung von purpurfarbenen Dekoren
ATE184024T1 (de) Verfahren zur herstellung von einer hyaluronsäurefraktion mit niedrigem polydispersionindex
DE69109427D1 (de) Blockcopolymerdispersionen und Verfahren zur Herstellung von Blockcopolymerdispersionen.
DE69522742T2 (de) Verfahren zur Herstellung von Kurzfasern
DE19581874T1 (de) Verfahren zur Herstellung von Verbundpolstern
DE69519253D1 (de) Verfahren zur Herstellung von plattenförmigem Bariumsulfat.
DE69510335T2 (de) Verfahren zur kontinuierlichen Herstellung von wässrigen Formaldehydlösungen
DE59100382D1 (de) Verfahren zur Reinigung von wässerigen N-Methylmorpholin-N-oxid-Lösungen.
DE59608917D1 (de) Hydrolysebeständige Polyesterfasern und -filamente, Masterbatches und Verfahren zur Herstellung von Polyesterfasern und -filamenten
DE69023681D1 (de) Verfahren zur Herstellung von Restriktionsendonuklease und -Methylase-MwoI.
DE68908550T2 (de) Verfahren zur Herstellung von korrosions-, wärme- und verschleissbeständigen Werkstücken und so hergestellte Werkstücke.
DE69512002D1 (de) Verfahren zur Herstellung von optisch aktiven Carbinolen
DE69505632T2 (de) Verfahren zur herstellung von cycloalkanolen und cycloalkanonen
DE69504764D1 (de) Galliumsilikat mit 12-Ring Poren (ECR-34) sowie Verfahren zu seiner Herstellung
DE69528966T2 (de) Feste Lösungen von Magnesiumhydroxid, Verfahren zur ihre Herstellung und ihre Anwendung
DE69508561T2 (de) Verfahren zur herstellung von 2,6-dichloropyridin
CH689291B5 (de) Verfahren zur Herstellung von Reservedruck-Faerbungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee